Expanding Treatment Options for Chronic Spontaneous Urticaria
Peanut Allergy Treatment Improves Quality of Life vs Peanut Avoidance
Patients With Chronic Urticaria May Face Higher Risk of Metabolic Syndrome
Smaller Trials, Bigger Impact: The Potential of Synthetic Data in CSU
Can Biomarkers Help Pinpoint the Right Treatment for Chronic Spontaneous Urticaria?
Exploring the Interplay of Spring Allergies, Inflammation, and Mental Health: Gary Falcetano, PA-C, AE-C
Patient Education, Provider Education, and Overall Final Thoughts
Navigating New Frontiers: Bruton Tyrosine Kinase Inhibitors in Chronic Spontaneous Urticaria Treatment
The Evaluation of Dupilumab In Chronic Spontaneous Urticaria Treatment
Key Updates Needed in Chronic Spontaneous Urticaria Guidelines
Addressing Persistent Symptoms in Chronic Spontaneous Urticaria: Beyond IgE-Targeted Treatments
The Use of Systemic Corticosteroids In Chronic Spontaneous Urticaria Treatment
Approaches to Switching Between Antihistamines and Other Medications When Treating Patients with Chronic Spontaneous Urticaria
Therapies Typically Used in the Firstline For Patients With Chronic Spontaneous Urticaria
Healthcare Specialties Involved in Managing Patients With Chronic Spontaneous Urticaria
Dupilumab Treatment for Patients With CSU: Insights From Jason Hawkes, MD, MS